For instance, one criterion is the presence of a breast tumour before the age of 60 that is estrogen and progesterone receptor negative with no overexpression of human epidermal growth factor receptor 2 (HER2), referred to as triple negative breast cancer (TNBC). The gene discussed is ERBB2; the disease is breast neoplasm.